Niquitin Clear (Nicotine)

Nicotine, the active ingredient in Niquitin Clear, is a nicotinic receptor agonist presented as a transdermal patch for transdermal use. It belongs to the smoking cessation therapeutic class and is used to alleviate nicotine withdrawal symptoms in adults seeking to quit tobacco use. The product complies with European Union medicinal regulations and is available over the counter across EU member states. It is manufactured under strict quality standards to ensure consistent nicotine delivery.

GNH USA supplies Niquitin Clear as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Niquitin Clear, a nicotine transdermal patch, is used in the smoking cessation pathway to help manage nicotine dependence.

Smoking cessation: provides a steady dose of nicotine through the skin to lessen cravings and withdrawal symptoms in adults attempting to quit smoking. Tobacco use disorder: offers controlled nicotine replacement therapy to support gradual reduction of nicotine intake. Nicotine dependence: delivers consistent plasma nicotine levels to aid in transitioning away from combustible cigarettes. Relapse prevention: maintains low nicotine levels to help prevent return to smoking after initial cessation.

Niquitin Clear may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Skin irritation at the application site - Sleep disturbance or insomnia - Nausea - Headache - Dizziness - Mouth irritation

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Cardiovascular events such as hypertension or arrhythmia - Respiratory depression - Seizures - Persistent skin ulceration - Stevens‑Johnson syndrome

Before using Niquitin Clear, consider the following precautions.

Assess nicotine dependence level: determine appropriate patch strength and duration as advised by a healthcare professional. Avoid use in patients with recent myocardial infarction: consult a physician before initiating therapy. Do not apply to damaged or irritated skin: select an intact area for placement. Rotate application sites: change location each day to minimize skin irritation. Discontinue if severe skin reaction occurs: seek medical advice promptly. Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Niquitin Clear can interact with other medicines; review the following.

Major Interactions (Avoid): - Concurrent use of monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Combining with other nicotine replacement products: risk of nicotine overdose. - Use with certain antihypertensive drugs (e.g., beta‑blockers): may blunt blood pressure response.

Moderate Interactions (Monitor Closely): - CYP2A6 inhibitors (e.g., methoxsalen): may increase nicotine plasma levels. - Alcohol consumption: can enhance nicotine's cardiovascular effects. - Use with psychiatric medications (e.g., antipsychotics): monitor for altered efficacy.